Maxy-Gamma

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMaxy-Gamma
Drug Alias Nameenhanced gamma IFN (Maxygen/InterMune)next-generation interferon gamma (Maxygen/InterMune)Maxy-50
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsImmune System DiseasesIdiopathic Pulmonary FibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxygen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxygenIntermune Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesIdiopathic Pulmonary FibrosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A